NCPA applauds PBM companion bill
By HME News Staff
Updated 9:48 AM CDT, Wed April 5, 2023
WASHINGTON – The National Community Pharmacists Association is cheering the bipartisan Drug Price Transparency in Medicaid Act (S. 1038), introduced March 29 by Sens. Peter Welch, D-Vt., and Roger Marshall, R-Kan., which would prevent pharmacy benefit managers from using spread pricing in Medicaid managed care programs. The bill is companion legislation to H.R. 1613, introduced March 16 by Reps. Buddy Carter, R-Ga., Vicente Gonzalez, D-Texas, Rick Allen, R-Ga., Jake Auchincloss, D-Mass., Elise Stefanik, R-N.Y., and Deborah Ross, D-N.C. “Stopping PBMs from abusing taxpayer dollars through harmful spread pricing and underwater reimbursements for pharmacies is a priority of NCPA’s,” said NCPA CEO B. Douglas Hoey, pharmacist, MBA. “We’re glad to see it’s increasingly a priority among members of Congress. We thank Sens. Welch and Marshall for introducing this bill and are eager to continue working together to move toward a fairer system for pharmacies and for patients.”
Comments